The effects of central and peripheral angiotensin on hypertension and nociception in rats

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 1-2, 1997, Pages 37-41

  Irvine, Rodney J ^a   White, Jason M ^a  

^a NONE

Author keywords

Analgesia; Angiotensin; Losartan; Spontaneously hypertensive rat; Wistar Kyoto rat

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; HYDRALAZINE; LOSARTAN; NORADRENALIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; HYPERTENSION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TAIL FLICK TEST;

ANALGESICS; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; CEREBRAL VENTRICLES; HYPERTENSION; IMIDAZOLES; INFUSION PUMPS, IMPLANTABLE; LOSARTAN; MALE; PAIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; REACTION TIME; TETRAZOLES;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030898646     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00166-9     Document Type: Article

References (24)

1. Braas, K. M.; Hendley, E. D. Anterior pituitary proopiomelanocortin expression is decreased in hypertensive rat strains. Endocrinology 134:196-205; 1994.
2. Bui, J. D.; Kimura, B.; Phillips, M. I. Losartan potassium, a non-peptide antagonist of angiotensin II, chronically administered PO does not readily cross the blood-brain barrier. Eur. J. Pharmacol. 219:147-151; 1992.
3. Bunag, R. D. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J. Appl. Physiol. 34:279-282; 1973.
4. Christensen, K. L.; Jespersen,L. T.; Mulvany, M. J. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J. Hypertens. 7:83-90; 1989.
5. DePasquale, M. J.; Fossa, A. A.; Holt, W. F.; Mangiapane, M. L. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension 19:668-671; 1992.
6. Erdos, E.G.; Skidgel, R. A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 3:145-151; 1989.
7. Fedoseeva, O. V.; Kalyuzhnyi, L. V.; Sudakov, K. V. New peptide mechanism of auriculo-acupuncture electro-analgesia: role of angiotensin II. Acupunct. Electrother. Res. 15:1-8; 1990.
8. Felder, R. A.; Garland, D. S. POMC biosynthesis in the intermediate lobe of the spontaneously hypertensive rat. Am. J. Hypertens. 2:618-624; 1989.
9. Gronan, R. J.; York, D. H. Effects of chronic intraventricular administration of angiotensin II on drinking behavior and blood pressure. Pharmacol. Biochem. Behav. 10:121-126; 1979.
10. Haulica, I.; Neamtu, C.; Stratone, A.; Petrescu, G.; Branisteanu, D.; Rosca, V.; Slatineanu, S. Evidence for the involvment of cerebral renin-angiotensin system (RAS) in stress analgesia. Pain 27:237-245; 1986.
11. Irvine, R. J.; White, J. M.; Head, R. J. The renin angiotensin system and nociception in spontaneously hypertensive rats. Life Sciences 56:1073-1078; 1995.
12. Knardahl, S.; Sagvolden, T. Open-field behavior of spontaneously hypertensive rats. Behav. Neural Biol. 27:187-200; 1979.
13. Lee, R. M.; Berecek, K. H.; Tsoporis, J.; McKenzie, R.; Triggle, C. R. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 17:141-150; 1991.
14. Maixner, W.; Touw, K. B.; Brody, M. J.; Gebhart, G. F.; Long, J. P. Factors influencing the altered pain perception in the spontaneously hypertensive rat. Brain Res. 237:137-145; 1982.
15. Roques, B. P.; Beaumont, A. Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives? Trends. Pharmacol. Sci. 11:245-249; 1990.
16. Ruiz, P.; Basso, N.; Cannata, M. A.; Taquini, A. C. The renin-angiotensin system in different stages of spontaneous hyperten-sion in the rat (SHR). Clin. Exp. Hypertens. A. 12:63-81; 1990.
17. Song, K. F.; Zhuo, J. L.; Mendelsohn, F. A. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors. Br. J. Pharmacol. 104:771-772; 1991.
18. Spinedi, E.; Negro Vilar, A. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. Neuroendocrinology. 37:446-453; 1983.
19. Steckelings, U.M.; Obermuller, N.; Bottari, S. P.; Qadri, F.; Veltmar, A.; Unger, T. Brain angiotensin: receptors, actions and possible role in hypertension. Pharmacol. Toxicol. 70:S23-7; 1992.
20. Unger, T.; Kaufmann Buhler, I.; Scholkens, B.; Ganten, D. Brain converting enzyme inhibition: a possible mechanism for the anti-hypertensive action of captopril in spontaneously hypertensive rats. Eur. J. Pharmacol. 70:467-478; 1981.
21. Whitehorn,D.; Atwater, D. G.; Low, W. C.; Gellis, J. E.; Hendley, E. D. Independence of blood pressure and locomotor hyperactivity in normotensive and genetically hypertensive rat. Behav. Neural Biol. 37:357-361; 1983.
22. Zamir, N.; Maixner, W. The relationship between cardiovascular and pain regulatory systems. Ann. N. Y. Acad. Sci. 467:371-384; 1986.
23. Zamir, N.; Simantov, R.; Segal, M. Pain sensitivity and opioid activity in genetically and experimentally hypertensive rats. Brain Res. 184:299-310; 1980.
24. Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals [editorial]. Pain 16:109-110; 1983.